Safety and efficacy of treating symptomatic, partial-thickness rotator cuff tears with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated at the point of care: a prospective,
Hurd JL., Facile TR., Weiss J., Hayes M., Hayes M., Furia JP.
Randomized Controlled Trial with a reported sample of 11 on Rotator Cuff, published in J Orthop Surg Res (2020) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Randomized Controlled Trial
- Journal
- J Orthop Surg Res (2020)
- Country
- England
- Reported sample size
- 11
- Source database
- PubMed
- PMID
- 32238172
- PMCID
- PMC7110715
- DOI
- 10.1186/s13018-020-01631-8
- NCT
- NCT02918136
- Citations
- 53
Abstract (original English)
Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection. Methods Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 10 6 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment. Results No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than t
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level AMeta-analysisEurope PMC
Surgical vs. non-surgical therapy for partial tears of the rotator cuff: a systematic review and meta-analysis of pooled studies with indirect comparison
Meta-analysis with a reported sample of 818 on Tendon Injury, Rotator Cuff, Shoulder Pain, published in BMC Musculoskelet Disord (2026) — summary generated from the PubMed abstract.
- 2026
- n = 818
BMC Musculoskelet Disord - Level AMeta-analysisEurope PMC
Comparison of nonsurgical treatment approaches for partial rotator cuff tears: a systematic review and meta-analysis
Meta-analysis with a reported sample of 137 on Rotator Cuff, Shoulder Pain, published in JSES Rev Rep Tech (2026) — summary generated from the PubMed abstract.
- 2026
- n = 137
JSES Rev Rep Tech - Level ASystematic ReviewPubMed
The role of injections of mesenchymal stem cells as an augmentation tool in rotator cuff repair: a systematic review.
Systematic Review with a reported sample of 5 on Tendon Injury, Rotator Cuff, published in JSES Rev Rep Tech (2025) — summary generated from the PubMed abstract.
- 2025
- n = 5
JSES Rev Rep Tech - Level ASystematic ReviewPubMed
Poor consideration of tissue loading in randomised trials of MSC interventions for tendon pathology: A systematic review using the TIDieR framework.
Systematic Review on Tendon Injury, Rotator Cuff, published in J Exp Orthop (2025) — summary generated from the PubMed abstract.
- 2025
J Exp Orthop - Level AMeta-analysisEurope PMC
Combined arthroscopic rotator cuff repair with mesenchymal stem cell augmentation shows similar functional outcomes but a higher structural integrity rate compared with isolated repair: a meta-analysis of comparative stu
Meta-analysis with a reported sample of 415 on Tendon Injury, Rotator Cuff, published in JSES Int (2025) — summary generated from the PubMed abstract.
- 2025
- n = 415
JSES Int